Since cancer stem cells (CSCs) exhibit high proliferative and migratory potential, it is important to assess the impact of knocking out CD133, the most commonly used classical surface marker of CSCs, and its expression regulator TRIM28 on these fundamental cellular functions. The gene discussed is TRIM28; the disease is cancer.